Australia markets open in 9 hours 1 minute

Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
76.31+0.82 (+1.09%)
At close: 4:02PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5193.16B
Enterprise value 3218.57B
Trailing P/E 27.45
Forward P/E 110.44
PEG ratio (5-yr expected) 11.35
Price/sales (ttm)4.02
Price/book (mrq)7.63
Enterprise value/revenue 34.55
Enterprise value/EBITDA 711.46

Trading information

Stock price history

Beta (5Y monthly) 0.43
52-week change 3-5.25%
S&P500 52-week change 349.51%
52-week high 387.80
52-week low 371.72
50-day moving average 375.48
200-day moving average 378.83

Share statistics

Avg vol (3-month) 312.03M
Avg vol (10-day) 39.78M
Shares outstanding 52.53B
Implied shares outstanding 6N/A
Float 2.5B
% held by insiders 10.09%
% held by institutions 175.69%
Shares short (14 Mar 2021) 418.14M
Short ratio (14 Mar 2021) 41.46
Short % of float (14 Mar 2021) 40.72%
Short % of shares outstanding (14 Mar 2021) 40.72%
Shares short (prior month 11 Feb 2021) 418.47M

Dividends & splits

Forward annual dividend rate 42.6
Forward annual dividend yield 43.41%
Trailing annual dividend rate 32.44
Trailing annual dividend yield 33.23%
5-year average dividend yield 42.94
Payout ratio 489.21%
Dividend date 306 Apr 2021
Ex-dividend date 411 Mar 2021
Last split factor 22:1
Last split date 316 Feb 1999

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin 14.72%
Operating margin (ttm)32.74%

Management effectiveness

Return on assets (ttm)11.16%
Return on equity (ttm)27.55%

Income statement

Revenue (ttm)47.99B
Revenue per share (ttm)18.97
Quarterly revenue growth (yoy)5.50%
Gross profit (ttm)34.57B
EBITDA 19.07B
Net income avi to common (ttm)7.07B
Diluted EPS (ttm)2.78
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.06B
Total cash per share (mrq)3.19
Total debt (mrq)33.45B
Total debt/equity (mrq)131.68
Current ratio (mrq)1.02
Book value per share (mrq)10.01

Cash flow statement

Operating cash flow (ttm)10.25B
Levered free cash flow (ttm)8B